|
PF-27483 |
LOWEX 15 mg. capsulas. |
2012-04-17 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-7157 |
RAPICAINE 2% Solución Inyectable |
2021-12-08 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-17277 |
ENALAPRIL Unipharm 5 mg Tabletas |
2020-10-22 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-17598 |
ANTIPRESS 5 mg Tabletas |
2026-07-14 |
|
Unipharm International, S.A. |
Guatemala
|
Medicin Farmacéutica |
Novoswiss Pharmaceuticals |
Centro Distribuidor, Sociedad Anónima |
Medwell International |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-11277 |
CLOXAPEN 500 mg Tabletas recubiertas |
2026-02-23 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Medicin Farmacéutica |
Novoswiss Pharmaceuticals |
Centro Distribuidor, Sociedad Anónima |
Medwell International |
Bodega Farmacéutica, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28207 |
ANSIBEN 20 mg Tabletas recubiertas |
2026-05-31 |
|
Unipharm International, S.A. |
Guatemala
|
Novoswiss Pharmaceuticals |
Medwell International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-17521 |
FUROSEMIDA Unipharm 40 mg Tabletas |
2021-09-02 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-18482 |
AXTAR 0.5 g IM Polvo para uso parenteral |
2026-02-03 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
Medwell International |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-18481 |
AXTAR 1.0 g IM Polvo para uso parenteral |
2026-02-11 |
|
Unipharm International, S.A. |
Guatemala
|
Medicin Farmacéutica |
Novoswiss Pharmaceuticals |
Centro Distribuidor, Sociedad Anónima |
Medwell International |
Agefinsa |
Bodega Farmacéutica, S.A. |
Reus Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-18296 |
MEDITONIC FORTE Jarabe |
2021-11-03 |
|
Novoswiss Pharmaceuticals |
Guatemala
|
Novoswiss Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|